UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 188

Sortiert nach

Amphetamine, past and present – a pharmacological and clinical perspective

Journal of psychopharmacology (Oxford), 2013-06, Vol.27 (6), p.479-496

2013

Volltextzugriff (PDF)

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids

Frontiers in psychiatry, 2024-06, Vol.15, p.1322434

2024

Volltextzugriff (PDF)

A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to d-amfetamine, methylphenidate and modafinil

Neuropharmacology, 2013-10, Vol.73, p.348-358

2013

Volltextzugriff (PDF)

What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials

International Journal of Obesity, 2022-04, Vol.46 (4), p.677-695

2022

Volltextzugriff (PDF)

Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology

Journal of Psychopharmacology, 2022-06, Vol.36 (6), p.680-703

2022

Volltextzugriff (PDF)

Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorder

Advances in pharmacology (1990), 2024, Vol.99, p.251

2024

Volltextzugriff (PDF)

Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans

Neuropharmacology, 2018-11, Vol.142, p.89-115

2018

Volltextzugriff (PDF)

Navacaprant, a novel and selective kappa opioid receptor antagonist, has no agonist properties implicated in opioid-related abuse

Neuropharmacology, 2024-10, Vol.257, p.110037, Article 110037

2024

Volltextzugriff (PDF)

Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective

Journal of psychopharmacology (Oxford), 2023-01, Vol.37 (1), p.33-44

2023

Volltextzugriff (PDF)

Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling

Neuropharmacology, 2022-11, Vol.218, p.109220-109220, Article 109220

2022

Volltextzugriff (PDF)

Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement

Journal of psychopharmacology (Oxford), 2021-10, Vol.35 (10), p.1204-1215

2021

Volltextzugriff (PDF)

Dopamine reuptake transporter (DAT) “inverse agonism” – A novel hypothesis to explain the enigmatic pharmacology of cocaine

Neuropharmacology, 2014-12, Vol.87, p.19-40

2014

Volltextzugriff (PDF)

Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats

Drug and alcohol dependence, 2022-02, Vol.231, p.109261-109261, Article 109261

2022

Volltextzugriff (PDF)

New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development

New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder, 2022-04, p.79-126

2022

Volltextzugriff (PDF)

Effects of lisdexamfetamine in a rat model of binge-eating

Journal of psychopharmacology (Oxford), 2015-12, Vol.29 (12), p.1290-1307

2015

Volltextzugriff (PDF)

Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the d-amphetamine prodrug, lisdexamfetamine

Journal of psychopharmacology (Oxford), 2017-06, Vol.31 (6), p.784-797

2017

Volltextzugriff (PDF)

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders

British journal of clinical pharmacology, 2009-12, Vol.68 (6), p.861-874

2009

Volltextzugriff (PDF)

What is the prognosis for new centrally-acting anti-obesity drugs?

Neuropharmacology, 2012-07, Vol.63 (1), p.132-146

2012

Volltextzugriff (PDF)

Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats

Journal of psychopharmacology (Oxford), 2014-03, Vol.28 (3), p.254-269

2014

Volltextzugriff (PDF)

Inhibition of alpha7 nicotinic receptors in the ventral hippocampus selectively attenuates reinstatement of morphine‐conditioned place preference and associated changes in AMPA receptor binding

Addiction biology, 2019-07, Vol.24 (4), p.590-603

2019

Volltextzugriff (PDF)

Dopamine and [mu]-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder

Journal of psychopharmacology (Oxford), 2017-06, Vol.31 (6), p.770

2017

Volltextzugriff (PDF)

Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model

Journal of psychopharmacology (Oxford), 2016-07, Vol.30 (7), p.662-675

2016

Volltextzugriff (PDF)

Thermogenic effects of sibutramine and its metabolites

British journal of pharmacology, 1999-03, Vol.126 (6), p.1487-1495

1999

Volltextzugriff (PDF)

Psychedelics – Re-opening the doors of perception

Neuropharmacology, 2018-11, Vol.142, p.1-6

2018

Volltextzugriff (PDF)

The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorder

Journal of psychopharmacology (Oxford), 2016-09, Vol.30 (9), p.848-855

2016

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(170)

Publikationsform

Sprache

Englisch
(187)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Amphetamine, past and present – a pharmacological and clinical perspective

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids

A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to d-amfetamine, methylphenidate and modafinil

What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials

Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology

Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorder

Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans

Navacaprant, a novel and selective kappa opioid receptor antagonist, has no agonist properties implicated in opioid-related abuse

Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective

Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling

Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement

Dopamine reuptake transporter (DAT) “inverse agonism” – A novel hypothesis to explain the enigmatic pharmacology of cocaine

Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats

New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development

Effects of lisdexamfetamine in a rat model of binge-eating

Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the d-amphetamine prodrug, lisdexamfetamine

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders

What is the prognosis for new centrally-acting anti-obesity drugs?

Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats

Inhibition of alpha7 nicotinic receptors in the ventral hippocampus selectively attenuates reinstatement of morphine‐conditioned place preference and associated changes in AMPA receptor binding

Dopamine and [mu]-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder

Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model

Thermogenic effects of sibutramine and its metabolites

Psychedelics – Re-opening the doors of perception

The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorder

Suchergebnisse filtern